Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients

• Register: ClinicalTrials.gov
• Last refreshed on: 17 October 2012
• Main ID: NCT00699868
• Date of registration: 13/06/2008
• Primary sponsor: Assistance Publique Hopitaux De Marseille
• Public title: Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients 2006/25
• Scientific title: Cellular Immunity, Cytomegalovirus Infection and Septic Shock in ICU Patients
• Date of first enrolment: March 2008
• Target sample size: 29
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT00699868
• Study type: Interventional
• Study design: Intervention Model: Parallel Assignment, Masking: Open Label

Countries of recruitment

France

Contacts

• Name: Jean-Marie FOREL, MD
• Affiliation: Assistance Publique des Hôpitaux de Marseille

Key inclusion & exclusion criteria

Inclusion Criteria:

- Age more than 18-year-old

- Informed consent

Exclusion Criteria:

- minors,

- pregnant or lactating women,

- adults under guardianship,

- immunosuppression at the entrance to resuscitation,

- AIDS



Age minimum: 18 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Cytomegalovirus Infection

Intervention(s)

Other: Sampling of blood, phenotypic analysis sub-populations NK by cytometric of stream in multiple markings

Primary Outcome(s)

Bring to light the quantitative and qualitative immunological modifications of the present cells NK before the arisen of an infection to CMV [Time Frame: 24 months]

Secondary Outcome(s)

Bring to light the quantitative and qualitative immunological modifications of cells NK in the consequences of an infectious shock [Time Frame: 24 months]

Secondary ID(s)

2007-A01197-46

Source(s) of Monetary Support

Please refer to primary and secondary sponsors